67 related articles for article (PubMed ID: 24788185)
1. One of the TNF superfamily members: bifunctional protein, TNFR2-Fc-IL-1ra.
Xie B
Methods Mol Biol; 2014; 1155():215-22. PubMed ID: 24788185
[TBL] [Abstract][Full Text] [Related]
2. A novel bifunctional protein TNFR2-Fc-IL-1ra (TFI): expression, purification and its neutralization activity of inflammatory factors.
Xie B; Liu S; Wu S; Chang A; Jin W; Guo Z; Ye S; Hui M
Mol Biotechnol; 2013 Jun; 54(2):141-7. PubMed ID: 22565853
[TBL] [Abstract][Full Text] [Related]
3. 5TNF-α and IL-1β neutralization ameliorates angiotensin II-induced cardiac damage in male mice.
Wang Y; Li Y; Wu Y; Jia L; Wang J; Xie B; Hui M; Du J
Endocrinology; 2014 Jul; 155(7):2677-87. PubMed ID: 24877626
[TBL] [Abstract][Full Text] [Related]
4. Characterization of 99mTc-labeled cytokine ligands for inflammation imaging via TNF and IL-1 pathways.
Liu Z; Wyffels L; Barber C; Wan L; Xu H; Hui MM; Furenlid LR; Woolfenden JM
Nucl Med Biol; 2012 Oct; 39(7):905-15. PubMed ID: 22749187
[TBL] [Abstract][Full Text] [Related]
5. SPECT imaging of inflammatory response in ischemic-reperfused rat hearts using a 99mTc-labeled dual-domain cytokine ligand.
Liu Z; Barber C; Wan L; Liu S; Hui MM; Furenlid LR; Xu H; Woolfenden JM
J Nucl Med; 2013 Dec; 54(12):2139-45. PubMed ID: 24179185
[TBL] [Abstract][Full Text] [Related]
6. Fine tuning of receptor-selectivity for tumor necrosis factor-α using a phage display system with one-step competitive panning.
Abe Y; Yoshikawa T; Inoue M; Nomura T; Furuya T; Yamashita T; Nagano K; Nabeshi H; Yoshioka Y; Mukai Y; Nakagawa S; Kamada H; Tsutsumi Y; Tsunoda S
Biomaterials; 2011 Aug; 32(23):5498-504. PubMed ID: 21546081
[TBL] [Abstract][Full Text] [Related]
7. [Cloning, expression and identification of IL-1ra-Fcepsilon fusion gene].
Liu Z; Zou M; Wang Y; Wang J; Xu D
Sheng Wu Gong Cheng Xue Bao; 2008 Oct; 24(10):1754-60. PubMed ID: 19149188
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor (TNF)-alpha-induced interleukin-8 in human blood cultures discriminates neutralization by the p55 and p75 TNF soluble receptors.
Frishman JI; Edwards CK; Sonnenberg MG; Kohno T; Cohen AM; Dinarello CA
J Infect Dis; 2000 Dec; 182(6):1722-30. PubMed ID: 11069245
[TBL] [Abstract][Full Text] [Related]
9. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.
Zwerina J; Hayer S; Tohidast-Akrad M; Bergmeister H; Redlich K; Feige U; Dunstan C; Kollias G; Steiner G; Smolen J; Schett G
Arthritis Rheum; 2004 Jan; 50(1):277-90. PubMed ID: 14730626
[TBL] [Abstract][Full Text] [Related]
10. A Dual Target-directed Agent against Interleukin-6 Receptor and Tumor Necrosis Factor α ameliorates experimental arthritis.
Kim Y; Yi H; Jung H; Rim YA; Park N; Kim J; Jung SM; Park SH; Park YW; Ju JH
Sci Rep; 2016 Feb; 6():20150. PubMed ID: 26841833
[TBL] [Abstract][Full Text] [Related]
11. A humanized tumor necrosis factor receptor 1 (TNFR1)-specific antagonistic antibody for selective inhibition of tumor necrosis factor (TNF) action.
Kontermann RE; Münkel S; Neumeyer J; Müller D; Branschädel M; Scheurich P; Pfizenmaier K
J Immunother; 2008 Apr; 31(3):225-34. PubMed ID: 18317365
[TBL] [Abstract][Full Text] [Related]
12. Lymphotoxin α induces apoptosis, necroptosis and inflammatory signals with the same potency as tumour necrosis factor.
Etemadi N; Holien JK; Chau D; Dewson G; Murphy JM; Alexander WS; Parker MW; Silke J; Nachbur U
FEBS J; 2013 Nov; 280(21):5283-97. PubMed ID: 23815148
[TBL] [Abstract][Full Text] [Related]
13. Synergism of toll-like receptor 2 (TLR2), TLR4, and TLR6 ligation on the production of tumor necrosis factor (TNF)-alpha in a spontaneous arthritis animal model of interleukin (IL)-1 receptor antagonist-deficient mice.
Jung YO; Cho ML; Lee SY; Oh HJ; Park JS; Park MK; Park MJ; Ju JH; Kim SI; Park SH; Kim HY; Min JK
Immunol Lett; 2009 Apr; 123(2):138-43. PubMed ID: 19428561
[TBL] [Abstract][Full Text] [Related]
14. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor-alpha antagonism by the murine tumor necrosis factor-alpha receptor 2-Fc fusion protein exacerbates histoplasmosis in mice.
Deepe GS
J Interferon Cytokine Res; 2007 Jun; 27(6):471-80. PubMed ID: 17572011
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-1 and tumor necrosis factor α blockade treatment of experimental polymyositis in mice.
Sugihara T; Okiyama N; Watanabe N; Miyasaka N; Kohsaka H
Arthritis Rheum; 2012 Aug; 64(8):2655-62. PubMed ID: 22392010
[TBL] [Abstract][Full Text] [Related]
17. [Expression of human tumor necrosis factor receptor-Fc fusion protein and characterization of its biological activity].
Du Z; Wang F; Zhu J; Yu J; Wang Y; Zhu X; Zhang W
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Mar; 30(3):225-8. PubMed ID: 24606734
[TBL] [Abstract][Full Text] [Related]
18. Development and characterization of a fusion protein between thermally responsive elastin-like polypeptide and interleukin-1 receptor antagonist: sustained release of a local antiinflammatory therapeutic.
Shamji MF; Betre H; Kraus VB; Chen J; Chilkoti A; Pichika R; Masuda K; Setton LA
Arthritis Rheum; 2007 Nov; 56(11):3650-61. PubMed ID: 17968946
[TBL] [Abstract][Full Text] [Related]
19. Induction of prostaglandin H synthase-2 and tumor necrosis factor-alpha in human amnionic WISH cells by various stimuli occurs through distinct intracellular mechanisms.
Hulkower KI; Otis ER; Li J; Ennis BW; Cugier DJ; Bell RL; Carter GW; Glaser KB
J Pharmacol Exp Ther; 1997 Feb; 280(2):1065-74. PubMed ID: 9023325
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
